| Trial ID: | L5485 |
| Source ID: | NCT00494559
|
| Associated Drug: |
Pioglitazone
|
| Title: |
The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Coronary Artery Stenosis
|
| Interventions: |
DRUG: Pioglitazone|DRUG: Placebo
|
| Outcome Measures: |
Primary: Comparison of pioglitazone and placebo on 8 months follow-up neointima volume by intravascular ultrasound (IVUS)., 8 month follow-up | Secondary: Comparison of pioglitazone and placebo on the changes in the levels of inflammatory markers (hsCRP, IL-6, TNF-α, adiponectin)., 8 months follow-up
|
| Sponsor/Collaborators: |
Sponsor: Korea University Anam Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
240
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-07
|
| Completion Date: |
2015-07
|
| Results First Posted: |
|
| Last Update Posted: |
2016-02-25
|
| Locations: |
Korea University Anam Hospital, Seoul, 136-705, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00494559
|
